Ultimovacs
Menu Close ✕
  • About
    • About Ultimovacs
    • Team
    • Board of directors
  • Technology
    • Technology overview
    • Immunotherapy
  • Clinical Studies
    • Phase II trials
    • Phase I trials
    • Expanded access
  • Investors
    • Shares
    • Financial reports
    • Presentations and Publications
    • Investor relations contacts
    • Analyst coverage
    • Governance
    • News
  • Contact
Ultimovacs  –  Investors

Investors

  • Shares

    We have strong financial and industrial shareholders.

    Read more
  • Financial reports

    Annual financial statements, quarterly reports and presentations.

    Read more
  • Investor relations contacts

    Please contact our IR Contacts for any queries.

    Read more
  • Press Releases

    Stock Exchange announcements and other news.

    Read more
  • Upcoming events

    List of events where the Ultimovacs team will attend or present.

    Read more
E-mail: mail@ultimovacs.com
Phone number: +47 413 80 080
Ullernchausséen 64
0379 Oslo
Norway
View in Google Maps

Technology

  • Technology
  • Clinical studies
  • Immunotherapy

Ultimovacs

  • About Ultimovacs
  • Team
  • Board of directors
  • Contact us

Investors

  • Share information
  • Financial reports
  • Investor relations contacts
  • News
Copyright © Ultimovacs ASA 2022